Delivery Order SPE2DB20D1047-SPE2DB25FF51V
Award Date
4/1/25
Potential Completion Date
4/2/25
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,007.02, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid dependence and alcohol dependence. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 4, 2025. The contract does not have a...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,288.63, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid dependence and alcohol dependence. The contract is a Delivery Order with a Firm Fixed Price pricing type, and an ultimate completion date of November 1, 2024. This award is not designated as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $3,966.60, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of opioid addiction and alcohol dependence. The contract has an ultimate completion date of April 30, 2024 and is a Firm Fixed Price Delivery Order. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,003.51, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid dependence and alcohol dependence. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 14, 2025. The contract is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,197.25 firm fixed-price delivery order contract is for the provision of VIVITROL 380 MG VIAL-DILUENTS, a specialty medication used for the treatment of opioid dependence and alcohol dependence. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,578.10, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid dependence and alcohol dependence. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $3,165.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of alcohol and opioid dependence. This is a Firm Fixed Price Delivery Order contract with a period of performance ending on March 28, 2025. The contract is not designated as a set-aside and was...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,002.34, is a delivery order for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and the contract is...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,097.75, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of opioid dependence and alcohol dependence. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is October 13, 2023. The contract has no set-aside...
This federal contract award, valued at $2,002.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of alcohol and opioid dependence. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 25, 2025. It is not designated as a set-aside...